VVOSVivos Therapeutics, Inc.
0.6452USD+5.77%Mkt Cap: 8.87M USDP/E: Last update: 2026-05-26

Vivos Therapeutics, Inc. operates as a medical technology and healthcare services company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), …

Indicators:|

Key Statistics

Company
Market Cap8.87M USD
Enterprise Value19.30M USD
Revenue (TTM)17.44M USD
Gross Profit10.54M USD
Net Income (TTM)-21.23M USD
Revenue/Share1.698 USD
Last Price0.6452 USD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees268
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-1.67
PEG
EV/EBITDA-1.04
EV/Revenue1.11
P/S0.47
P/B1.91
EPS (TTM)-2.14
EPS (Forward)-0.35
52W Range
0.54501% of range7.950
52W High7.950 USD
52W Low0.5450 USD
Profitability
Gross Margin60.44%
Oper. Margin-166.89%
EBITDA Margin-106.55%
Profit Margin-121.71%
ROE1424.83%
ROA-84.41%
Growth
Revenue Growth3.40%
Earnings Growth
Cash Flow & Leverage
Operating CF-15.26M USD
CapEx (TTM)2.34M USD
FCF Margin-53.96%
FCF Yield-106.17%
Net Debt11.47M USD
Net Debt/EBITDA-0.62
Balance Sheet
Debt/Equity-9.06
Current Ratio0.24
Quick Ratio0.20
Book Value/Sh0.3060 USD
Cash/Share0.1500 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1:25
Split DateOct 27, 2023
Analyst Consensus
Rating
Target (Mean)2.417 USD
Target Range1.750 USD3.000 USD
# Analysts3
Ownership
Shares Out.13.89M
Float11.67M
Insiders26.06%
Institutions14.25%
Short Interest
Short Ratio1.9d
Short % Float6.61%
Short % Out.5.26%
Shares Short716.11K
Short (prev mo.)316.12K
Technical
SMA 501.003 (-35.7%)
SMA 2002.230 (-71.1%)
Beta6.21
S&P 52W Chg28.31%
Avg Vol (30d)239.84K
Avg Vol (10d)160.53K
Technical Indicators
RSI (14)
MACD
MACD Signal
MACD Hist.
BB Upper
BB Middle
BB Lower
BB Width
ATR (14)
Vol Ratio (20d)